Re: Lovastatin for Reduction of Leptin in Nondialysis Patients With Type 2 Diabetic Nephropathy. (2014). Iranian Journal of Kidney Diseases, 8(4), 344-345. https://ijkd.org/index.php/ijkd/article/view/1793